GNI Group Ltd. (TYO:2160)
3,590.00
+475.00 (15.25%)
At close: Mar 6, 2026
GNI Group Revenue
In the year 2025, GNI Group had annual revenue of 26.84B JPY with 13.68% growth. GNI Group had revenue of 7.48B in the quarter ending December 31, 2025, with 16.58% growth.
Revenue
26.84B
Revenue Growth
+13.68%
P/S Ratio
7.45
Revenue / Employee
30.96M
Employees
867
Market Cap
199.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.84B | 3.23B | 13.68% |
| Dec 31, 2024 | 23.61B | -2.40B | -9.22% |
| Dec 31, 2023 | 26.01B | 8.59B | 49.33% |
| Dec 31, 2022 | 17.42B | 4.73B | 37.26% |
| Dec 31, 2021 | 12.69B | 2.92B | 29.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takara Bio | 44.15B |
| Nxera Pharma | 29.62B |
| PeptiDream | 18.52B |
| RaQualia Pharma | 3.98B |
| Japan Tissue Engineering | 2.26B |
| AnGes | 874.00M |
| Cuorips | 356.00M |
| Renascience | 107.00M |